Amgen Q1 2022 Earnings Preview
JHVEPhoto/iStock Editorial via Getty Images


Amgen (NASDAQ:AMGN) is scheduled to announce Q1 earnings results on Wednesday, April 27th, after market close.
The consensus EPS Estimate is $4.16 (+12.4% Y/Y) and the consensus Revenue Estimate is $6.15B (+4.2% Y/Y).
Over the last 2 years, AMGN has beaten EPS estimates 88% of the time and has beaten revenue estimates 75% of the time.

Over the last 3 months, EPS estimates have seen 4 upward revisions and 5 downward. Revenue estimates have seen 0 upward revisions and 7 downward.
The company's 2022 guidance:



The consensus 2022 Revenue estimate is $26.12B and EPS estimate is $17.62.
In Q4, Amgen Non-GAAP EPS beat Street estimates, but revenue of $6.85B missed estimates by $20M.

Wall Street analysts on average rated AMGN Hold, with an average price target of $245.82.
stock has risen 11% YTD.